Mouse, man, and meaning: bridging the semantics of mouse phenotype and human disease

被引:16
|
作者
Hancock, John M. [1 ]
Mallon, Ann-Marie [1 ]
Beck, Tim [1 ]
Gkoutos, Georgios V. [2 ]
Mungall, Chris [3 ]
Schofield, Paul N. [4 ]
机构
[1] MRC, Bioinformat Grp, Harwell OX11 0RD, Oxon, England
[2] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England
[3] Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA
[4] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England
基金
英国医学研究理事会; 英国生物技术与生命科学研究理事会;
关键词
ONTOLOGY; DATABASE; EMPRESS; TOOL; MUTAGENESIS;
D O I
10.1007/s00335-009-9208-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Now that the laboratory mouse genome is sequenced and the annotation of its gene content is improving, the next major challenge is the annotation of the phenotypic associations of mouse genes. This requires the development of systematic phenotyping pipelines that use standardized phenotyping procedures which allow comparison across laboratories. It also requires the development of a sophisticated informatics infrastructure for the description and interchange of phenotype data. Here we focus on the current state of the art in the description of data produced by systematic phenotyping approaches using ontologies, in particular, the EQ (Entity-Quality) approach, and what developments are required to facilitate the linking of phenotypic descriptions of mutant mice to human diseases.
引用
收藏
页码:457 / 461
页数:5
相关论文
共 50 条
  • [31] Bridging mouse and human anatomies; a knowledge-based approach to comparative anatomy for disease model phenotyping
    Jesús Ruberte
    Paul N. Schofield
    John P. Sundberg
    Alfonso Rodriguez-Baeza
    Ana Carretero
    Colin McKerlie
    Mammalian Genome, 2023, 34 : 389 - 407
  • [32] MouseFinder: Candidate Disease Genes from Mouse Phenotype Data
    Chen, Chao-Kung
    Mungall, Christopher J.
    Gkoutos, Georgios V.
    Doelken, Sandra C.
    Koehler, Sebastian
    Ruef, Barbara J.
    Smith, Cynthia
    Westerfield, Monte
    Robinson, Peter N.
    Lewis, Suzanna E.
    Schofield, Paul N.
    Smedley, Damian
    HUMAN MUTATION, 2012, 33 (05) : 858 - 866
  • [33] Sleep phenotype in the Townes mouse model of sickle cell disease
    O'Donnell, Brett J.
    Guo, Lanping
    Ghosh, Samit
    Shah, Faraaz A.
    Strollo, Patrick J., Jr.
    McVerry, Bryan J.
    Gladwin, Mark T.
    Ofori-Acquah, Solomon F.
    Kato, Gregory J.
    O'Donnell, Christopher P.
    SLEEP AND BREATHING, 2019, 23 (01) : 333 - 339
  • [34] Sleep phenotype in the Townes mouse model of sickle cell disease
    Brett J. O’Donnell
    Lanping Guo
    Samit Ghosh
    Faraaz A. Shah
    Patrick J. Strollo
    Bryan J. McVerry
    Mark T. Gladwin
    Solomon F. Ofori-Acquah
    Gregory J. Kato
    Christopher P. O’Donnell
    Sleep and Breathing, 2019, 23 : 333 - 339
  • [35] MEANING OF MOUSE TESTS FOR CARCINOGENESIS
    GOLBERG, L
    ANNALS OF ALLERGY, 1971, 29 (04): : 229 - &
  • [36] Trehalose alleviates the phenotype of Machado–Joseph disease mouse models
    Magda M. Santana
    Susana Paixão
    Janete Cunha-Santos
    Teresa Pereira Silva
    Allyson Trevino-Garcia
    Laetitia S. Gaspar
    Clévio Nóbrega
    Rui Jorge Nobre
    Cláudia Cavadas
    Hagar Greif
    Luís Pereira de Almeida
    Journal of Translational Medicine, 18
  • [37] A transgenic mouse model with an inducible skin blistering disease phenotype
    Takahashi, K
    Coulombe, PA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (25) : 14776 - 14781
  • [38] The Behavioral phenotype of a transgenic mouse model of Alzheimer's disease
    Sood, A
    Buccafusco, JJ
    Terry, AV
    FASEB JOURNAL, 2005, 19 (05): : A1543 - A1543
  • [39] THE PSYCHIATRIC AND METABOLIC PHENOTYPE OF THE BACHD MOUSE MODEL OF HUNTINGTON DISEASE
    Cheong, R.
    Lundh, S. Hult
    Kirik, D.
    Petersen, A.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 : A28 - A28
  • [40] Transgenic mouse models of Alzheimer's disease: phenotype and application
    Higgins, GA
    Jacobsen, H
    BEHAVIOURAL PHARMACOLOGY, 2003, 14 (5-6): : 419 - 438